Antibody Response in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19. (COV-HD)
A Comparison of Antibody Response Against SARS-CoV-2 in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19.
Sponsor: Saint Petersburg State University, Russia
A observational or N/A phase clinical study on Covid19 and Dialysis, this trial is completed. The trial is conducted by Saint Petersburg State University, Russia and has accumulated 9 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Sep 2021 — Dec 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 4 earlier versions
-
Apr 2021 — Sep 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Feb 2021 — Apr 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting
First recorded
Nov 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Saint Petersburg State University, Russia
For direct contact, visit the study record on ClinicalTrials.gov .